Sign in
4

Changes in Ownership

Kura Oncology, Inc. Filed Acc 0000950170-25-108844

President and CEO bought 50,000 shares at an average $6.06 ($303,201)

From the SEC's structured data for this filing

Trades in this filing

WILSON TROY EDWARD · President and CEO

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-12 Purchase : show line 1 in the form +36,506 $5.85 $213,578 37,474 D
2025-08-13 Purchase : show line 2 in the form +13,494 $6.64 $89,623 50,968 D
Open-market purchases · 50,000 sh · avg $6.06 · $303,201
Loading xslF345X05/ownership.xml…